2 results
Approved WMOPending
To find the maximum tolerated dose of glass yttrium-90 (90Y) microspheres (TheraSphere®), when combined with DEBIRI in patients with liver-dominant colorectal liver metastases (CRLM).
Approved WMORecruiting
The primary performance objective is to demonstrate bone formation assessed based on bone height measurements, in the maxillomandibular region after filling extraction sockets with FF-37101. Secondary and exploratory performance objectives of this…